Bank of America Corp DE Increases Holdings in LifeStance Health Group, Inc. (NASDAQ:LFST)

Bank of America Corp DE raised its position in LifeStance Health Group, Inc. (NASDAQ:LFST - Free Report) by 30.1% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 396,662 shares of the company's stock after purchasing an additional 91,796 shares during the period. Bank of America Corp DE owned 0.10% of LifeStance Health Group worth $2,923,000 as of its most recent filing with the Securities and Exchange Commission.

Other large investors also recently modified their holdings of the company. Jennison Associates LLC increased its position in shares of LifeStance Health Group by 278.4% in the 4th quarter. Jennison Associates LLC now owns 8,086,380 shares of the company's stock valued at $59,597,000 after purchasing an additional 5,949,438 shares during the last quarter. Handelsbanken Fonder AB purchased a new stake in shares of LifeStance Health Group in the 4th quarter valued at approximately $128,000. Blue Trust Inc. grew its position in shares of LifeStance Health Group by 124.4% in the 4th quarter. Blue Trust Inc. now owns 3,828 shares of the company's stock valued at $27,000 after buying an additional 2,122 shares during the last quarter. Northern Trust Corp grew its position in shares of LifeStance Health Group by 11.7% in the 4th quarter. Northern Trust Corp now owns 1,591,776 shares of the company's stock valued at $11,731,000 after buying an additional 166,731 shares during the last quarter. Finally, Geode Capital Management LLC grew its position in shares of LifeStance Health Group by 0.4% in the 4th quarter. Geode Capital Management LLC now owns 3,465,471 shares of the company's stock valued at $25,546,000 after buying an additional 13,293 shares during the last quarter. 85.50% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling at LifeStance Health Group

In other news, insider Lisa K. Miller sold 18,845 shares of the business's stock in a transaction on Monday, March 17th. The shares were sold at an average price of $6.90, for a total transaction of $130,030.50. Following the completion of the sale, the insider now directly owns 339,810 shares of the company's stock, valued at $2,344,689. The trade was a 5.25% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. 3.20% of the stock is currently owned by insiders.

Analyst Ratings Changes

A number of analysts recently weighed in on LFST shares. UBS Group upgraded shares of LifeStance Health Group from a "neutral" rating to a "buy" rating and set a $8.50 price target for the company in a research note on Tuesday, May 27th. Canaccord Genuity Group began coverage on LifeStance Health Group in a report on Thursday, April 3rd. They issued a "buy" rating and a $8.00 price objective on the stock. KeyCorp began coverage on LifeStance Health Group in a report on Tuesday, April 8th. They issued an "overweight" rating and a $9.00 price objective on the stock. Finally, William Blair reiterated an "outperform" rating on shares of LifeStance Health Group in a research report on Friday, February 28th. One research analyst has rated the stock with a sell rating, four have assigned a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat, LifeStance Health Group presently has a consensus rating of "Moderate Buy" and an average price target of $8.50.

LifeStance Health Group Trading Down 1.0%

LFST traded down $0.06 during trading on Monday, hitting $5.88. The company's stock had a trading volume of 1,792,884 shares, compared to its average volume of 1,592,618. The firm's 50 day moving average price is $6.32 and its 200-day moving average price is $7.12. The company has a debt-to-equity ratio of 0.19, a current ratio of 1.32 and a quick ratio of 1.32. The stock has a market cap of $2.29 billion, a PE ratio of -22.62 and a beta of 1.30. LifeStance Health Group, Inc. has a twelve month low of $4.64 and a twelve month high of $8.61.

LifeStance Health Group Profile

LifeStance Health Group, Inc, through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy.